🇺🇸 FDA
Patent

US 10603356

Compositions and method for treatment of inflammatory bowel disease

granted A61KA61K38/10A61K38/12

Quick answer

US patent 10603356 (Compositions and method for treatment of inflammatory bowel disease) held by The Regents of the University of California expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/10, A61K38/12, A61K38/1729, A61K38/55